å»è¬åå ¬è¡šãããæŽå¯
Osteonecrosisã¯éªšçްèã骚ã«è¡ã®æµãã®æ¬ åŠã«ãã骚现èã®ãã€ã¹ã骚ã厩å£ããç æ°ã§ãã è¡ç®¡ç¥çµçãç¡èç¥çµçãŸãã¯èè¡æ§ç¥çµçãšããŠãç¥ãããŠããŸãã Osteonecrosisã¯è©ãæéŠãæè¶³ããã³ãã£ãŒãã§ããå°ãªãé »ç¹ã«éããããã®éªš(femur)ãèã§æãäžè¬ã«çºéããŸãã 軜床ããé床ã®çã¿ãåŒãèµ·ããã埮å°éªšæã«ã€ãªããå¯èœæ§ããããŸãã Osteonecrosisã¯Xç·ãCTã¹ãã£ã³ãMRIã骚ã¹ãã£ã³ããã³æ©èœéªšãã¹ãã䜿çšããŠèšºæããããšãã§ããŸãã Osteonecrosisã®åŠçœ®ã¯åŸŽåãç®æšã«ããæ¥µç«¯ãªå Žåã®è¬ç©ãå€ç§ã«ãã£ãŠèŠçãæžãããŸãã åžå°çŸæ£ã®åœ... ãã£ãšèŠã
æ¿ãã䟵襲çã¢ã¹ãã«ã®ã«çã¯ãã¢ã¹ãã«ãžã«èã«ããæ¥æ§ææçãŸãã¯çèæé·ã§ãã ã»ãšãã©ã®äººã¯ã¢ã¹ãã«ãžã«ã¹èãšæ¥è§ŠããŠããŸããã誰ããææã«ææã§ã¯ãããŸããã ã¢ã¹ãã«ã®ã«çã¯ã䟵襲çã¢ã¹ãã«ã®ã«çãæ ¢æ§èºã¢ã¹ãã«ã®ã«çãã¢ã¬ã«ã®ãŒæ§æ°ç®¡è «çãã¢ã¬ã«ã®ãŒæ§ã¢ã¹ãã«ã®ã«çãã¢ã¬ã«ã®ãŒæ§ã¢ã¹ãã«ã®ã«çãã¢ã¹ããŒãžã«çãããã³ç²èçãªã©ã®ããŸããŸãªã¿ã€ãã«åé¡ãããŸãã æŽ»åçãªäŸµè¥²çãªã¢ã¹ãã«ã®ã«ç(IA)ã¯ãå ç«æåã®æ£è ãèºçŸæ£ã«èŠããã§ãã人ã«åœ±é¿ãäžãããŸãã§ãäžåè¡¡ãããã³æ·±å»ãªçèææçã§ãã 䟵襲çãªã¢ã¹ããŒãžçã®äŒæã®éçºã«è²¬ä»»ãããå±éºå åã¯åŒ±ããããå ç«ã·ã¹ãã ãäœãçœè¡... ãã£ãšèŠã
ã¢ãžã¢å€ªå¹³æŽã€ãã°ã«ã»ã©ãŒãŒåžå Žã匷床å¥ïŒ400 IUããã³200 IUïŒããã©ã³ãå¥ïŒã»ã¬ã¶ã€ã ãã¢ããµãŒãã³ããã®ä»ïŒãå°åå¥ïŒäžåœãã€ã³ããã·ã³ã¬ããŒã«ãã¿ã€ããããã ããã¬ãŒã·ã¢ããã£ãªãã³ãã€ã³ããã·ã¢ãã«ã³ããžã¢ãããã³ãã®ä»ã®ã¢ãžã¢å€ªå¹³æŽå°åïŒ... ãã£ãšèŠã
Thrombocytopeniaã¯æ£è ãè¡äžã®è¡å°æ¿ã®äœã¬ãã«ãæã£ãŠããé害ã§ãã è¡å°æ¿æžå°çã®äž»ãªåå ã¯ãè¡å°æ¿ãè¡å°æ¿ã®èŸèã®åé¢ãããã³è¡å°æ¿ã®å éç Žå£ã®éå¹ççãªçç£ã§ãã è¡æ çã®æãäžè¬çãªéæå¹ãªçç£ã¯ãéªšé«æ§çå矀ããã©ã¹ããã¯è²§è¡ãªã©ã®éªšé«ã®æ éçå矀ã§ãã Thrombocytopeniaã¯ç¶æ¿ãŸãã¯ååŸããããšãã§ããŸãã ã§ 2014, å°éå®¶ã®Med Jã§å ¬è¡šã®ç ç©¶èšäºã«ãããšã, 2014, ããã³ãã·ãŒãopeniaã®åšæ³¢æ°, thrombocytopeniaã®åšæ³¢æ°ã¯ãé«éœ¢è ã®ããã®ããé«ãã§ã 60 æ³ä»¥äž, éè¡çªèçŸæ£ã«èŠãã. ããããªãããã¿ã³ãã... ãã£ãšèŠã
è³åäžã¯è¡æ¶²ååºãè¡ç®¡ããããã¯ããè¡æ¶²ã®æµããè³ã«é®æããçŽ°èæ»ã«è³ãç¶æ ã§ãã ã¢ã¡ãªã«ã³ã¹ãããŒã¯åäŒã®ã¬ã€ãã©ã€ã³ã§ã¯ã3çš®é¡ã®ã¹ãããŒã¯ããããŸã:èè¡æ§è³åäž(è³ã«è¡æ¶²ãå±ããè¡ç®¡å ã®éå¡)ãåºè¡æ§è³åäž(é«è¡å§ã«ããè¡ç®¡ã®æŽå)ãããã³éæž¡æ§èè¡æ§çºäœ(äžæçãªè æã«ãã£ãŠèå¥ããã)ã é«è¡å§ãç³å°¿ç ãå¿èç ããŸãã¯å«ç ã身äœçã«äžæŽ»æ§ãªã©ã€ãã¹ã¿ã€ã«ãã¢ã«ã³ãŒã«ä¹±çšãè¥æºãªã©ã®ããŸããŸãªç¿æ £ãªã©ã®å»åŠçæ¡ä»¶ã«èµ·å ããã¹ãããŒã¯ã¯åŒãèµ·ããããšãã§ããŸãã ãŸããé«éœ¢åãç·æ§ã®æ§ãéºäŒæ§ãæ°ææ§ãªã©ã®å¶åŸ¡äžèœãªèŠå ãè³åã«è²¢ç®ããŸãã 2015幎ã«äžçä¿å¥æ©é¢(WHO)ã«ãããš... ãã£ãšèŠã
æ¥æ§ãªã³ãèœçæ§çœè¡ç(ALL)ã¯ã骚é«ãè¡æ¶²ã«åœ±é¿ãäžããçã®äžçš®ã§ãã æ¡ä»¶ã¯ããªã³ãèœçްèãšãåŒã°ããèªç¶çœè¡çã®éå°çç£ã«ãã£ãŠç¹åŸŽä»ããããŸãã äžåäžãŸãã¯ç°åžžãªçްèã¯ãé©åã«æ©èœããå¥åº·ãªçްèã®åšãã«æ§ç¯ããããšã¯ã§ããŸããã ãã¹ãŠã®æ£è ã¯ãåçºææãè²§è¡ãåºè¡ãããã³éªšé«ãèµ€è¡çãçœè¡çããã³è¡å°æ¿ã®ååãªæ°ã圢æã§ããªãããã容æã«å·ã€ãããšã¯éåžžã«ææã§ãã ããã¯é«ãé²è¡çãç¹åŸŽãšããæ°ãæä»¥å ã«æ²»çããªããšèŽåœçã§ããã ãã现èã¯ããªã³ãç¯ãèèãèŸèãäžæ¢ç¥çµç³»ãå«ãäœã®ä»ã®èåšã«åºããå¯èœæ§ãããã ç¶æ ã®äžè¬çãªçç¶ã«ã¯ãè äžå šãèºçãåŒåžåšçŸæ£ãããã³éªšã®ç... ãã£ãšèŠã
äºæ¬¡ç²ç¶è ºæ©èœäº¢é²ç(SHPT)ã¯ãäž»ã«ç²ç¶è ºãã«ã¢ã³ãããã©ã«ä»£è¬ç°åžžãããã³å¯ç²ç¶è ºæ©èœäº¢é²çã®é«ã¬ãã«ã«ãã£ãŠç¹åŸŽä»ããããæ ¢æ§è çŸæ£(CKD)ãšé¢é£ããæ·±å»ãªãå ±éããã³é²è¡å䜵çã®1ã€ãæããŸãã ç æ°ã®è èã¯ããã¿ãã³Aããã®æŽ»æ§åœ¢æ ã«å€ããããšãã§ããªããããäœå ã§äžæº¶æ§ã«ã«ã·ãŠã ãªã³é žå¡©ã®åœ¢æã«é©ããªããããäºæ¬¡ç²ç¶è ºæ©èœäº¢é²ã«ã€ãªããã ç æ°ã®äžè¬çãªåŸŽåããã³åŸŽåã¯éªšããã³æ¥åç®æã®èŠçããŸãè¢ã®å€åœ¢ãå«ãã§ããŸãã äºæ¬¡ç²ç¶è ºæ©èœäº¢é²çã®æ£è ã«åŒãèµ·ããããé害ã¯ãçåœãšçåœã®æåŸ ã®æªãå質ã«ã€ãªããå¯èœæ§ããããŸãã SHPTã®ããã®åŠçœ®ã¯å諟ãããã¿ãŒã²ããåºåå ã®å¯... ãã£ãšèŠã
å»è¬åã°ã¬ãŒãã®æ°Žé žåãã°ãã·ãŠã åžå ŽãçŽåºŠå¥ (99%)ããšã³ããŠãŒã¶ãŒå¥ (補è¬äŒç€Ÿãåèšç ç©¶æ©é¢ããã®ä»)ãå°åå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
ãã£ãŒã«ãã®é²æ© ãã€ãªãã¯ãããžãŒ è¬ã®åµè¬ããã»ã¹ãéããŠãè¬ã®åœ¢ã§æå¹æåãèå¥ããããã«ãå»è¬åã¯åŸã ã«åžå Žã§ããŒã¹ãäžããŠããŸãã ãã®è¬ã®çºèŠããã»ã¹ã¯ãååŠçã©ã€ãã©ãªã®ã¹ã¯ãªãŒãã³ã°ãèªç¶çæ³ã®ããã®æå¹æåã®ç¹å®ããŸãã¯éèã®çºèŠãå«ã¿ãŸãã ãŠã€ã«ã¹ãŸãã¯æææ§çŸæ£ãå«ãæ°ããç æ°ã®å䜵çã¯ããããã®æ¡ä»¶ã®è¬ç©çºèŠã®éèŠãé«ãã ããããè¬ã®éçºã¯è€éã§ãã³ã¹ãããããããªã¹ã¯ã®ããããã»ã¹ã§ããè¬ã®çºèŠã®ç®çã¯æ®µéãåèšåºç ç©¶ã«ãã£ãŠèª¿æ»ã®è¬å€ã®æåçã調æ»ã®æ°ããè¬å€ã®å¡åžç·éIãèªèããããšã§ãã 第IIçžã第IIIçžè©Šéšãæ°è¬å¿çšã第IVçžè©Šéšã åµè¬ããã»ã¹ã®æå... ãã£ãšèŠã
ã€ã³ãã®ãã¥ãŒãã©ã·ã¥ãŒãã£ã«ã«ãºã³ã©ãŒã²ã³åžå Žã補åã¿ã€ãå¥ïŒãŒã©ãã³ãå æ°Žåè§£ã³ã©ãŒã²ã³ã倩ç¶ã³ã©ãŒã²ã³ãåæã³ã©ãŒã²ã³ïŒãäŸçµŠæºå¥ïŒåç©ããŒã¹ããã³æ€ç©ããŒã¹ïŒã補å€å¥ïŒç²æ«ãã¯ãªãŒã ããã§ã€ã¹ãã¹ã¯/ãã§ã€ã¹ã·ãŒããã°ããã«ãã»ã«ã溶液ãªã©ïŒãçšéå¥ïŒãã¢ã±ã¢ããªãŒã©ã«ã±ã¢ãã¹ãã³ã±ã¢ãã¢ã€ã±ã¢ãæŽåœ¢å€ç§ã±ã¢ãããã³ ãã®ä»ïŒã販売ãã£ãã«å¥ïŒãªã³ã©ã€ã³ããã³ãªãã©ã€ã³ïŒ... ãã£ãšèŠã
æ ¢æ§èºã¢ã¹ãã«ã®ã«ç(CPA)ã¯ãäžççãªèå»¶ã䌎ãèºã®æ·±å»ãªé·æçèçŸæ£ã§ãã æ ¢æ§èºã¢ã¹ãã«ã®ã«ç(CPA)ã¯ãçµæ žãæ ¢æ§é塿§èºçŸæ£ããã³ãµã«ã³ã€ããŒã·ã¹ãå«ãæ¡ä»¶ãè€éã«ããé«ã眹æ£çãšæ»äº¡çã«é¢é£ããŠããŸãã æ ¢æ§ã®èºã¢ã¹ãã«ã®ã«ç(CPA)ã¯ãèºãã«ããã®ãã£ãããšé²è¡çç Žå£ã«ãã£ãŠç¹åŸŽä»ããããŸããè€æ°ã®ãã£ããã£ãããŒãã«ãã€ã³ãã£ã«ããŸãã¯ç·ç¶çã®åäžã®åœ¢æ ã§ã¯ãã¢ã¹ãã«ã®ã«ãã®æç¡ã«ããããããäžççãªæ ¢æ§ã¢ã¹ãã«ã®ã«çæ²»çåžå Žã¯ãè©äŸ¡ããããšæšå®ããã US$ 2,916.3 çŸäžå ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠4.8ããŒã»ã³ã äºå ±æéäž (2... ãã£ãšèŠã
Eisenmengerã·ã³ãããŒã ã¯é«ãããéçºããŸã è¡å§ èºã§ã¯ãèºé«è¡å§ãšããŠç¥ãããŠããã èºé«è¡å§ã¯ãç¹å®ã®å 倩æ§å¿ãå¿èã®å·ŠåŽããå³åŽã«ç°åžžã«æµããããã«è¡æ¶²ãåŒãèµ·ããåå ã§èµ·ãããŸã(å·Šããå³ãž)ã ãã®æ¡ä»¶ãåŒãèµ·ãããå 倩ã®å¿æ¬ é¥ã¯ãç¹èš±å€§è žåè硬åç(PDA)ãã¢ããªã«ã®é颿§æ¬ æ(ASD)ããã³ããªã«ã®éèæ¬ é¥(VSD)ãããã³ã¢ãªãªãã³ãã©ã«éæ²³ã®æ¬ é¥(AVéæ²³)ãå«ã¿ãŸãã ãã®shuntã®é転ã¯ãå¿èã®å³åŽããå·ŠåŽ(å³ããå·Šã®ã·ã£ã³ã)ãžã®è¡ã®éåã¯ãè¡æ¶²äžã®äžååãªé žçŽ äŸçµŠãåŒãèµ·ãããŸãã ãã®é転ã¯ãå¿èã®å³åŽã«è¡å§ãå¢å ãããããšã«ããèµ·ãããè¡æ¶²ãå·ŠåŽã«... ãã£ãšèŠã
ç±³åœã¡ãŒã«ãŒåŠæ¹è¬ã¯ãŒãã³åžå Žãå²åŒã¿ã€ãå¥ïŒã¡ãŒã«ãŒè²¯èã«ãŒããåŠæ¹ç®å²åŒã«ãŒããè¬å±å²åŒã¯ãŒãã³ïŒãæ²»çåéå¥ïŒç³å°¿ç ãæãŠã€ã«ã¹è¬ãæé¢ç¯çè¬ãæé«èè¡çè¬ãåŒåžåšè¬ãçŒç§è¬ãè «çåŠãé®çè¬ãæææçè¬ããã®ä»ïŒãæµéãã£ãã«å¥ïŒãªã³ã©ã€ã³ããã³ãªãã©ã€ã³ïŒ... ãã£ãšèŠã
æ°Žç£é€æ®ã¯ã¯ãã³åžå Žãçš®å¥ïŒéãç²æ®»é¡ãè»äœåç©ãªã©ïŒãã¯ã¯ãã³ã®çš®é¡å¥ïŒäžæŽ»åïŒæ»æ» ïŒã¯ã¯ãã³ãç匱æ¯åã¯ã¯ãã³ãDNAã¯ã¯ãã³ãªã©ïŒãç åäœã®çš®é¡å¥ïŒçްèã¯ã¯ãã³ããŠã€ã«ã¹ã¯ã¯ãã³ãå¯çè«ã¯ã¯ãã³ãªã©ïŒããšã³ããŠãŒã¶ãŒå¥ïŒåæ¥æ°Žç£é€æ®å Žãåµåå Žãç ç©¶æ©é¢ããã³å€§åŠãªã©ïŒãå°çå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
èèç·ç¶çã¯ç¹å®ã®ç¶æ ã§ã¯ãªããå¥ã®èèã®åé¡ã®çç¶ã§ã¯ãããŸããã èç·ç¶çã¯çç¶èªäœãåŒãèµ·ãããŸããã ãã«ã¹ã±ã¢ã®å°éå®¶ã¯ãèç·ç¶çã®åå ãæ²»çããããšã«ãããèç·ç¶çã®æ²»çã«çŠç¹ãåãããèèã®ç¢çã黿¢ãŸãã¯é ãããŸãã æ ¢æ§ã¢ã«ã³ãŒã«é£²æãèªå·±å ç«èçããŠã£ã«ãœã³ç ãGalactosemiaãFruuctosemiaãã°ãªã³ã²ã³è²¯èµç æ°ãéç©ã¿éãã®åŸŽåã ã¬ãŠãã£ãŒç ã现èãå¯çè«ããã³ãŠã€ã«ã¹ææãèè¡æµã«åœ±é¿ãäžããé害ã®ããã€ãã¯ãèèç·ç¶ç管çã«é¢é£ããå¯èœæ§ã®ããå±éºå åã®ããã€ãã§ãã ããã«ãèç·ç¶çæ²»çåžå Žã¯ãéã¢ã«ã³ãŒã«æ§å¹¹çްèç(NASH)æ²»çã§å¢å ããŒã¹ã... ãã£ãšèŠã
ããããè¬ã¯ããã®ç¹åŸŽã®é«ã掻åã«èµ·å ããããã€ãã®ç æ°ã«å¯ŸããŠäœ¿çšãããæœåšçãªæ²»çè¬ã§ã, ã¿ãŒã²ããç¹ç°æ§, äœæ¯æ§, æå°éã®éç¹ç°çãŸãã¯è¬ç©äŸåçžäºäœçš. æ¹åããããããããè¬å€ã®ããã®å£é èŠæ±ã管çãããšãè²§ããèã®éç£çããã³äœãã¿ãŒã²ããç¹å®ã®è¡çºã®ãããªäœãphysicochemicalç¹æ§ã ãããããã®Glycosylationã¯ãããããè¬å€ã®physicochemicalç¹æ§ã調ç¯ããçç©çèãæž¡ããããããã®æµžéã®ããã®ææãªäœæŠã§ãã ã°ãªã³ã·ã¬ãŒã·ã§ã³ã® ãããã 2ã€ã®ã¿ã€ãã®Nãªã³ã¯ãããç³éãŸãã¯Oãªã³ã¯ãããç³éã®ã©ã¡ãã§ããå ŽåããããŸãã ããã... ãã£ãšèŠã
Alveolar rhabdomyosarcoma(ARMS)ã¯ã骚ãçèãè»éªšãé垯ãªã©ã®èº«äœã®çµåçµç¹ããçããè»çµç¹ã®ãµã«ãã®äžçš®ã§ãã åäŸã®è «çåŠã°ã«ãŒãã2011幎ã«ãã調æ»ã«ãããšãè»çšéŒ»è «ã¯RMSã®çŽ25-40%ãå ããã ARMSã¯é幎ã§ã»ãšãã©æ€åºããããã°ãã°è ãèãèžãããã³èã«çºçããŸãã ã¢ã«ããããšãµã«ãã®æ£ç¢ºãªåå ã¯äžæã§ãããNeurofibromatosisã¿ã€ã1ãBeckwith-Wiedemannçå矀ãLi-Fraumeniçå矀ãCardio-facio-cutaneousçå矀ãCostelloçå矀ãªã©ã®ä»ã®æ¡ä»¶ã«é¢é£ä»ããããŠããŸãã ARM... ãã£ãšèŠã
ç±³åœããã³ãšãŒãããã®çäœå è¬çåŠåžå ŽããµãŒãã¹ã¿ã€ãå¥ïŒæ¯ç©åŠç ç©¶ãPKããã³PDç ç©¶ãæå€§èçšéç ç©¶ããã€ãªããŒã«ãŒæ€æ»ããã³çç©åæãåç©çŸæ£ã¢ãã«ãADMEç ç©¶ãªã©ïŒãã¢ããªã±ãŒã·ã§ã³å¥ïŒè «çåŠãççããã³å ç«åŠãå¿èåŠãç¥çµåŠãçŒç管çãç·ç¶çãä»£è¬æ§çŸæ£ãåŒåžåšçŸæ£ãææçãªã©ïŒãçµäºãŸã§ ãŠãŒã¶ãŒïŒãã€ãªãã¯ãããžãŒäŒæ¥ã補è¬äŒç€Ÿãåèšç ç©¶æ©é¢ïŒCROïŒãªã©ïŒ... ãã£ãšèŠã